Generation of histocompatible tissues using nuclear transplantation.
about
Can mammalian cloning combined with embryonic stem cell technologies be used to treat human diseases?Engineering tissue from human embryonic stem cellsTissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapyApplications of regenerative medicine in organ transplantationStem cell therapy for incontinence: where are we now? What is the realistic potential?Scaffolds from surgically removed kidneys as a potential source of organ transplantationAdult human CD133/1(+) kidney cells isolated from papilla integrate into developing kidney tubulesSomatic cell dedifferentiation/reprogramming for regenerative medicineKidney regeneration: Where we are and future perspectivesSurvival of skin graft between transgenic cloned dogs and non-transgenic cloned dogs.Challenges and future of renal replacement therapy.The future of organ replacement: needs, potential applications, and obstacles to application.Renal differentiation of amniotic fluid stem cells.Cloning adult farm animals: a review of the possibilities and problems associated with somatic cell nuclear transfer.Current strategies and challenges in engineering a bioartificial kidney.Tissue engineering: current strategies and future directionsDevelopmental approaches to kidney tissue engineering.The role of stem cells for treatment of cardiovascular disease.Tissue engineering for the replacement of organ function in the genitourinary system.Fusion of approaches to the treatment of organ failure.The ability of mouse nuclear transfer embryonic stem cells to differentiate into primordial germ cellsImmune problems in central nervous system cell therapy.Adult stem cells in renal injury and repair.Potential Use of Autologous Renal Cells from Diseased Kidneys for the Treatment of Renal Failure.Tissue engineering, stem cells and cloning: current concepts and changing trends.Applications of tissue engineering in the genitourinary tract.Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies.Cellular therapies for kidney failure.The potential of stem cell therapies for neurological diseases.Technology insight: Applications of tissue engineering and biological substitutes in urology.Why the apparent haste to clone humans?Human embryonic stem cells: preclinical perspectivesExploring stem cell biology with small molecules.The future of cell therapy for myocardial regeneration.Staged in vitro reconstitution and implantation of engineered rat kidney tissue.The pharmacology of regenerative medicineCurrent progress with primate embryonic stem cellsProlongation of life in anephric rats following de novo renal organogenesis.Application of regenerative medicine for kidney diseasesStem cell and regenerative science applications in the development of bioengineering of renal tissue.
P2860
Q24544165-EBFFA8AE-64D3-49F4-88D6-5F9E1D31B8C2Q24657199-D5D33391-4B0A-4B44-860B-A28FDF368434Q24809660-9F5D639E-20DE-4B86-8B6F-BC509D9D3DC3Q26801226-E4A13934-77AF-4247-90B6-E9F8C13004A3Q26827498-32ACBDB3-C0D1-4BDF-B9EB-2C4DB29894B1Q28083866-E79159CA-130A-44AF-9BE4-518806F4FB8BQ30503942-44E16B3E-371D-41E0-8430-AFD802267E55Q33614812-38B32EBB-9F07-44AB-9ED2-1D9840B859D1Q34367647-5CE57E55-16C7-454D-8851-CE9A1305B720Q34455887-3596D3E5-F87F-4266-AE4B-287C9A5C89B7Q34488921-90FEBBE7-606C-4467-8CD0-5DC5D983A7EEQ34665254-43ACBB3D-62A5-4B86-B4FE-26A87B149C8FQ34714561-7B34C58A-34D4-444B-A98F-B1C2E5738C40Q35170857-F60B54E8-36C6-4718-954D-8521FC9FABE2Q35251426-C0D02C17-D926-444B-9D5E-A99BF44AC336Q35546159-D480F5F2-275A-43F9-BDDA-FAFF7D9FC7BBQ35600693-6B079CA3-58DF-42D4-A0B1-3D639C0BACD0Q35661004-E1E890DF-C8CF-4980-B9F8-D699E261B14CQ35661050-877BE6E3-CE34-4057-AA54-6D9A31B6F616Q35661055-81EFC1CA-8F93-47C1-88DF-B17AFE7D1497Q35933620-6A1CAD41-C8DC-4494-AD10-4383607EAC57Q36045396-C5504A95-715A-4CC9-9447-6F3589BDA103Q36164072-F013A7D3-F3E5-4449-B878-0F999444DC54Q36173144-9056A355-3DF6-4CA0-893A-B22C0B0EA75EQ36194058-E5A86663-E563-4543-88BB-1F13C41CA7F1Q36314994-3748E1F2-DE3D-42C4-BA12-87D5DDE68801Q36321463-41D9B747-4229-4E55-A244-856792C6D498Q36377192-7560C55B-2A0B-4C05-8EAA-22929947125EQ36390804-D1B4B8C1-BD4D-49F1-8DE1-CD26BF03366DQ36395130-C142D9C7-AD59-45F4-BDEA-1AE51652CB29Q36464059-A17DD81D-BD41-49E3-9570-7FCA3CFF3693Q36498790-C087C5D8-1F4D-434B-94B8-32391882C45FQ36553089-1D10A520-237D-4D06-83C2-80DE9B44E25BQ36559150-9C5426CC-0C6A-454E-AF30-49E5FBBECDF0Q36693382-FC25206D-6931-4CE0-B4DA-85FD8EF57ADFQ36974665-1ADC0733-19A6-4443-BC3C-A437F468B358Q37066438-D97EC32E-0EA6-4CC6-AA9B-3A49CEB59F6CQ37079370-034DEF23-EA4B-4831-A044-1285F777425EQ37113335-07D8A3C3-D6E3-46BB-A33A-4AF19A182FC0Q37143890-7D2E1141-319E-46D4-96B4-7BE01DE8D700
P2860
Generation of histocompatible tissues using nuclear transplantation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Generation of histocompatible tissues using nuclear transplantation.
@ast
Generation of histocompatible tissues using nuclear transplantation.
@en
Generation of histocompatible tissues using nuclear transplantation.
@nl
type
label
Generation of histocompatible tissues using nuclear transplantation.
@ast
Generation of histocompatible tissues using nuclear transplantation.
@en
Generation of histocompatible tissues using nuclear transplantation.
@nl
prefLabel
Generation of histocompatible tissues using nuclear transplantation.
@ast
Generation of histocompatible tissues using nuclear transplantation.
@en
Generation of histocompatible tissues using nuclear transplantation.
@nl
P2093
P2860
P356
P1433
P1476
Generation of histocompatible tissues using nuclear transplantation
@en
P2093
Carlos T Moraes
Catherine Blackwell
Erik Hofmeister
Gunter Schuch
Ho Yun Chung
James J Yoo
Michael D West
Nancy Borson
Peter J Wettstein
Shay Soker
P2860
P2888
P304
P356
10.1038/NBT703
P577
2002-06-03T00:00:00Z